US Senator

John Hoeven Authored & Sponsored Legislation

Session

Co-Sponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB224

Introduced
1/23/25  
Promoting Domestic Energy Production Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB230

Introduced
1/23/25  
Unborn Child Support Act This bill requires states to apply child support obligations to the time period during pregnancy. This requirement is applicable retroactively based on a court order at the request of the pregnant parent and a determination by a physician of the month during which the child was conceived. Existing state requirements are applicable to these obligations, such as proof of parenthood.
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB237

Introduced
1/23/25  
Refer
1/23/25  
Honoring Our Fallen Heroes Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB252

Introduced
1/24/25  
GOOD Act Guidance Out Of Darkness Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB272

Introduced
1/28/25  
Protect Infant Formula from Contamination ActThis bill imposes certain new requirements on infant formula manufacturers and the Food and Drug Administration (FDA) following the discovery of contaminated, adulterated, or misbranded infant formula. Specifically, the bill requires infant formula manufacturers to report to the FDA within one business day of learning that formula that was processed by the manufacturer but that is no longer within the manufacturer’s control may not provide required nutrients or may be otherwise adulterated or misbranded. Further, if any testing of finished infant formula reveals the presence of specified microorganisms (e.g., salmonella), the manufacturer must notify the FDA within one business day. (Under current law, manufacturers are only required to report contamination to the FDA if the affected formula has left the manufacturer’s control.) The manufacturer must also promptly provide the test results to the FDA and consult with the FDA on proper isolation and disposal of the affected product. The FDA must respond to such a notification and begin discussing proper investigative and corrective action with the manufacturer within one business day. Within 90 days of a report of adulterated, misbranded, or contaminated infant formula, the FDA must determine whether the manufacturer that reported the problem has performed, or is performing, appropriate investigative and corrective action. Finally, the FDA is required to periodically report on the infant formula supply chain and efforts to improve the safety and supply of infant formula, and must consult with other federal agencies and infant formula stakeholders on these issues.  
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB315

Introduced
1/29/25  
Refer
1/29/25  
AM Radio for Every Vehicle Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB364

Introduced
2/3/25  
Hearing Protection Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB383

Introduced
2/4/25  
JOBS Act of 2025 Jumpstart Our Businesses by Supporting Students Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB390

Introduced
2/4/25  
Refer
2/4/25  
BADGES for Native Communities Act Bridging Agency Data Gaps and Ensuring Safety for Native Communities Act
US

Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB401

Introduced
2/4/25  
Fair Access to Banking Act